Chong Kun Dang Holdings Appoints Choi Hee Nam as New CEO

On the 28th, Chong Kun Dang Holdings held its regular general meeting of shareholders and board of directors, and announced on the 29th that it had appointed Choi Hee-nam as its CEO.

Choi Hee-nam, the new CEO of Chong Kun Dang Holdings (left), and Park Wan-gap, the new CEO of Chong Kun Dang Bio
[Photo by each company]

Newly appointed CEO Choi earned a bachelor's and master's degree in economics from Hanyang University and a Ph.D. in economics from the University of Pittsburgh in the United States. He served as the Managing Director of the International Monetary Fund (IMF) in 2016 and was the President of the Korea Investment Corporation (KIC) in 2018. Since 2022, he has been recognized as an economic expert, serving as the Chairman of the Board of SC First Bank and a Global Fellow at the Milken Institute, an American economic think tank.

Meanwhile, Chong Kun Dang Bio, an affiliate company, also held its regular general meeting of shareholders and board of directors on the 28th and appointed Park Wan-gap as its CEO. Newly appointed CEO Park earned a bachelor's degree in chemistry and a master's degree in inorganic chemistry from Hanyang University. He joined Kyungbo Pharmaceutical in 2010, worked in overseas sales and procurement for 14 years, and has been serving as the head of the Active Pharmaceutical Ingredient (API) sales division since 2022.